If you need more lookups,
subscriptions start at $34 USD/month.
Gareth Hicks Location
United States
Gareth Hicks Work
Co-founder, CEO and Board Member @ Nocicera Therapeutics (October 2024 - Present)
Co-founder, CSO and Board Member @ Severn Therapeutics (August 2020 - Present)
Co-founder, Board Member and ad-interim CEO @ Endosome Therapeutics (August 2017 - Present)
Entrepreneur in Residence @ (January 2024 - June 2024)
Vice President and Head Gastrointestinal Drug Discovery Unit @ (April 2014 - December 2023)
Chief Scientific Officer and Head of Scientific and Clinical Affairs @ Tioga Pharmaceuticals, Inc. (April 2011 - March 2014)
Search and Evaluation, Business Development @ (May 2008 - February 2011)
Head Neuroscience Medical Affairs, Novartis Pharmaceuticals Corporation @ (September 2007 - May 2008)
Head, Gastroenterology and Urology Clinical Development and Medical Affairs, Novartis Pharmaceuticals Co @ (May 2006 - September 2007)
Senior Director, Gastroenterology Medical Affairs, Novartis Pharmaceuticals Corporation @ (September 2004 - May 2006)
Head, Gastrointestinal Disease Research @ (January 2004 - September 2004)
Neurology and Gastrointestinal Research @ (January 1996 - January 2004)
Gareth Hicks Education
University of Cambridge
PhD (Pharmacology)
1990-1994
UCL
BSc (Pharmacology)
1987-1990
Gareth Hicks Summary
Gareth Hicks, based in United States, is currently a Co-founder, CEO and Board Member at Nocicera Therapeutics. Gareth Hicks brings experience from previous roles at Severn Therapeutics, Endosome Therapeutics and Takeda. Gareth Hicks holds a 1990 - 1994 PhD in Pharmacology @ University of Cambridge. Gareth Hicks has 2 emails on RocketReach.
Looking for a different Gareth Hicks?
Find contact details for 700 million professionals.